United Kingdom Stent Market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027. The rising incidences of cardiovascular disorders across the United Kingdom are primarily driving the growth of the market. In addition to this, the proliferating cases of several ailments such as ischemic heart disease, peripheral artery disease (PAD), and aortic aneurysm is also adding to the market growth. Moreover, the growing geriatric population across the UK, who are more prone to such ailments, is further adding to the product demand. Apart from this, the sedentary lifestyle, unhealthy eating choices, along with high consumption of alcohol, and smoking habits, are adding to the occurrences of such severe ailments, which eventually is providing a thrust to the United Kingdom stent market.
Stent refers to a small mesh tube that is primarily utilized to open and hold passages in the body, particularly in weak and narrow coronary arteries. This provides the heart with oxygen-rich blood. Stents are generally inserted in an angioplasty procedure where plaque blocks a blood vessel. They are inserted either as an emergency to treat a heart attack or in a planned manner to wide open an artery that is blocked by fatty plaque.
Rising Preferences for Minimally Invasive Procedures Fuel the Market Growth
Rising Prevalence of Cardiovascular and Lifestyle Diseases Drives the Product Demand
In 2020, people aged 65+ accounted for the share of 18.65% out of 67.26 million population in United Kingdom
DOWNLOAD FREE SAMPLE REPORT
Market Segmentation
Company Profile
Medtronic United Kingdom, Abbott Laboratories Limited, Boston Scientific Limited, Becton, Dickinson U.K. Limited, Stryker (UK) Limited, Conmed UK Limited, and B. Braun Medical Limited are the key leading companies of United Kingdom stent market.
Attribute | Details |
Base Year | 2021 |
Historical Data | 2017 – 2020 |
Estimated Year | 2022 |
Forecast Period | 2023 – 2027 |
Quantitative Units | Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027 |
Report coverage | Revenue forecast, value forecast, company share, competitive landscape, growth factors, and trends |
Segments covered | · Product Type · Material Type · Type · End Users |
Regional scope | London, East Anglia, Southwest, Southeast, Scotland, East Midlands, and Yorkshire & Humberside |
Key companies profiled | Medtronic United Kingdom, Abbott Laboratories Limited, Boston Scientific Limited, Becton, Dickinson U.K. Limited, Stryker (UK) Limited, Conmed UK Limited, and B.Braun Medical Limited |
Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |